327 related articles for article (PubMed ID: 18523073)
1. Noninvasive imaging of cell-mediated therapy for treatment of cancer.
Akins EJ; Dubey P
J Nucl Med; 2008 Jun; 49 Suppl 2(0 2):180S-95S. PubMed ID: 18523073
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive cell-tracking methods.
Kircher MF; Gambhir SS; Grimm J
Nat Rev Clin Oncol; 2011 Sep; 8(11):677-88. PubMed ID: 21946842
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing.
Saeed M; Xu Z; De Geest BG; Xu H; Yu H
Bioconjug Chem; 2020 Feb; 31(2):404-415. PubMed ID: 31951380
[TBL] [Abstract][Full Text] [Related]
4. Part II: targeted particles for imaging of anticancer immune responses.
Hung RW; Hamdy S; Haddadi A; Ghotbi Z; Lavasanifar A
Curr Drug Deliv; 2011 May; 8(3):274-81. PubMed ID: 21291375
[TBL] [Abstract][Full Text] [Related]
5. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
6. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).
Liu Z; Li Z
Theranostics; 2014; 4(10):990-1001. PubMed ID: 25157278
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging for Monitoring Cellular and Immunotherapy of Cancer.
Larimer BM
Cancer J; 2024 May-Jun 01; 30(3):153-158. PubMed ID: 38753749
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in cancer immunotherapy.
Gunzer M; Grabbe S
Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
[TBL] [Abstract][Full Text] [Related]
10. Advances in PET Detection of the Antitumor T Cell Response.
McCracken MN; Tavaré R; Witte ON; Wu AM
Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
[TBL] [Abstract][Full Text] [Related]
12. Personalized cancer vaccines.
Jain KK
Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
[TBL] [Abstract][Full Text] [Related]
13. Current issues in dendritic cell cancer immunotherapy.
López JA; Hart DN
Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
[TBL] [Abstract][Full Text] [Related]
14. Cell transfer-based immunotherapies in cancer: A review.
Gorabi AM; Hajighasemi S; Sathyapalan T; Sahebkar A
IUBMB Life; 2020 Apr; 72(4):790-800. PubMed ID: 31633881
[TBL] [Abstract][Full Text] [Related]
15. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer using dendritic cells.
Morse MA; Lyerly HK
Cytokines Cell Mol Ther; 1998 Mar; 4(1):35-44. PubMed ID: 9557215
[TBL] [Abstract][Full Text] [Related]
17. Whole-Body Imaging to Assess Cell-Based Immunotherapy: Preclinical Studies with an Update on Clinical Translation.
Sato N; Choyke PL
Mol Imaging Biol; 2022 Apr; 24(2):235-248. PubMed ID: 34816284
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based cancer therapy.
Conrad C; Nestle FO
Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
Bhargava A; Mishra D; Banerjee S; Mishra PK
Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
[TBL] [Abstract][Full Text] [Related]
20. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy.
Farkas A; Conrad C; Tonel G; Borbenyi Z; Kemeny L; Dobozy A; Nestle FO
Skin Pharmacol Physiol; 2006; 19(3):124-31. PubMed ID: 16612139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
